MGX
Metagenomi Therapeutics, Inc.
Company overview
- Market capitalization
- $43.07M
- Employees
- 119
- Latest publication
- 2026-09-29
About Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Financial statements
Income Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 22,512,000USD | 19,300,000USD | 21,501,000USD | 23,959,000USD | 22,507,000USD | 25,142,000USD | 23,164,000USD | 26,256,000USD |
| Total Operating Expenses | 28,516,000USD | 25,835,000USD | 26,978,000USD | 30,174,000USD | 6,993,000USD | 31,947,000USD | 30,237,000USD | 33,897,000USD |
| Net Income | -27,482,000USD | -23,059,000USD | -22,528,000USD | -20,393,000USD | -19,908,000USD | -25,039,000USD | -23,398,000USD | -18,773,000USD |
| Total Revenue | — | 1,248,000USD | 3,911,000USD | 8,659,000USD | 8,513,000USD | 4,127,000USD | 9,614,000USD | 11,514,000USD |
| Gross Profit | — | 1,248,000USD | 2,611,000USD | 7,335,000USD | -13,994,000USD | 4,127,000USD | 9,614,000USD | 11,514,000USD |
| Selling General Administrative | — | 6,535,000USD | 6,777,000USD | 6,215,000USD | 6,993,000USD | 6,805,000USD | 7,073,000USD | 7,641,000USD |
| Operating Income | — | -24,587,000USD | -24,367,000USD | -22,839,000USD | -20,987,000USD | -27,820,000USD | -20,623,000USD | -22,383,000USD |
| Interest Income | — | 1,539,000USD | 1,884,000USD | 2,214,000USD | 2,485,000USD | 2,887,000USD | 3,196,000USD | 3,616,000USD |
| Net Interest Income | — | 1,539,000USD | 1,884,000USD | 2,214,000USD | 2,485,000USD | 2,887,000USD | 3,196,000USD | 3,616,000USD |
| Income Before Tax | — | -23,049,000USD | -22,494,000USD | -20,627,000USD | -19,864,000USD | -24,941,000USD | -24,606,000USD | -20,879,000USD |
| Income Tax Expense | — | -10,000USD | 34,000USD | -234,000USD | 44,000USD | 98,000USD | -1,208,000USD | -2,106,000USD |
| Tax Provision | — | 10,000USD | 34,000USD | -234,000USD | 44,000USD | 98,000USD | -1,208,000USD | -2,106,000USD |
| Net Income From Continuing Ops | — | -23,059,000USD | -22,528,000USD | -20,393,000USD | -19,908,000USD | -25,039,000USD | -23,398,000USD | -18,773,000USD |
| Ebitda | — | -23,049,000USD | -23,067,000USD | -19,303,000USD | -19,652,000USD | -26,462,000USD | -19,162,000USD | -21,019,000USD |
| Reconciled Depreciation | — | 1,275,000USD | 1,300,000USD | 1,324,000USD | 1,335,000USD | 1,358,000USD | 1,461,000USD | 1,364,000USD |
| Total Other Income Expense Net | — | 1,538,000USD | 1,873,000USD | 2,212,000USD | 1,123,000USD | 2,879,000USD | -3,983,000USD | 1,504,000USD |
| Cost Of Revenue | — | — | 1,300,000USD | 1,324,000USD | 22,507,000USD | — | 1,461,000USD | — |
| Unclassified Operating Expenses | — | — | -1,300,000USD | — | -22,507,000USD | — | — | — |
| Ebit | — | — | -24,367,000USD | -20,627,000USD | -20,987,000USD | -27,820,000USD | -20,623,000USD | -22,383,000USD |
| Depreciation And Amortization | — | — | 1,300,000USD | 1,324,000USD | 1,335,000USD | 1,358,000USD | 1,461,000USD | 1,364,000USD |
| Source | 0001193125-26-342388Preliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Total Revenue | 25,210,000USD | 52,295,000USD | 44,756,000USD | 17,200,000USD | 243,000USD |
| Cost Of Revenue | 5,317,000USD | 5,407,000USD | 94,403,000USD | 1,733,000USD | 387,000USD |
| Gross Profit | 19,893,000USD | 52,295,000USD | -49,647,000USD | 15,467,000USD | -144,000USD |
| Research Development | 94,433,000USD | 109,179,000USD | 94,403,000USD | 43,139,000USD | 14,478,000USD |
| Selling General Administrative | 26,790,000USD | 32,017,000USD | 28,845,000USD | 18,701,000USD | 9,712,000USD |
| Unclassified Operating Expenses | -5,317,000USD | — | -94,403,000USD | -1,733,000USD | — |
| Total Operating Expenses | 115,906,000USD | 141,196,000USD | 28,845,000USD | 60,107,000USD | 23,803,000USD |
| Operating Income | -96,013,000USD | -88,901,000USD | -78,492,000USD | -44,640,000USD | -23,947,000USD |
| Interest Income | 9,470,000USD | 14,722,000USD | 15,468,000USD | 3,419,000USD | 43,000USD |
| Net Interest Income | 9,470,000USD | 14,722,000USD | 15,468,000USD | 3,321,000USD | -259,000USD |
| Income Before Tax | -87,926,000USD | -83,571,000USD | -60,228,000USD | -41,024,000USD | -21,442,000USD |
| Income Tax Expense | -58,000USD | -5,513,000USD | 8,026,999USD | 2,569,000USD | 306,000USD |
| Tax Provision | -58,000USD | -5,513,000USD | 8,027,000USD | 2,569,000USD | 0USD |
| Net Income | -87,868,000USD | -78,058,000USD | -68,255,000USD | -43,593,000USD | -21,442,000USD |
| Net Income From Continuing Ops | -87,868,000USD | -78,058,000USD | -68,255,000USD | -43,593,000USD | -21,442,000USD |
| Ebit | -96,013,000USD | -88,901,000USD | -78,492,000USD | -40,926,000USD | -21,140,000USD |
| Ebitda | -90,696,000USD | -83,494,000USD | -74,285,000USD | -39,193,000USD | -20,753,000USD |
| Depreciation And Amortization | 5,317,000USD | 5,407,000USD | 4,207,000USD | 1,733,000USD | 387,000USD |
| Reconciled Depreciation | 5,317,000USD | 5,407,000USD | 4,207,000USD | 1,733,000USD | 387,000USD |
| Total Other Income Expense Net | 8,087,000USD | 5,330,000USD | 18,264,000USD | 3,616,000USD | 2,505,000USD |
| Interest Expense | — | — | 0USD | 98,000USD | 302,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 173,701,000USD | 196,953,000USD | 221,103,000USD | 247,937,000USD | 272,284,000USD | 297,866,000USD | 324,599,000USD | 358,348,000USD |
| Total Liabilities | 61,134,000USD | — | — | — | — | — | — | — |
| Other Current Assets | — | 4,396,000USD | 4,434,000USD | 4,746,000USD | 5,815,000USD | 6,213,000USD | 8,396,000USD | 7,117,000USD |
| Total Liab | — | 59,168,000USD | 62,507,000USD | 69,490,000USD | 76,453,000USD | 85,208,000USD | 89,742,000USD | 102,575,000USD |
| Total Stockholder Equity | — | 137,785,000USD | 158,596,000USD | 178,447,000USD | 195,831,000USD | 212,658,000USD | 234,857,000USD | 255,773,000USD |
| Other Current Liab | — | 4,690,000USD | 6,719,000USD | 9,897,000USD | 5,924,000USD | 6,120,000USD | 8,422,000USD | 8,840,000USD |
| Common Stock | — | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Capital Stock | — | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Retained Earnings | — | -333,929,000USD | -310,870,000USD | -288,342,000USD | -267,949,000USD | -248,041,000USD | -223,002,000USD | -199,604,000USD |
| Cash | — | 25,306,000USD | 41,722,000USD | 32,773,000USD | 26,850,000USD | 29,195,000USD | 27,386,000USD | 25,117,000USD |
| Cash And Short Term Investments | — | 140,162,000USD | 160,799,000USD | 184,114,000USD | 204,993,000USD | 225,970,000USD | 248,307,000USD | 274,587,000USD |
| Total Current Assets | — | 144,558,000USD | 165,538,000USD | 189,820,000USD | 211,681,000USD | 233,195,000USD | 257,960,000USD | 282,293,000USD |
| Total Current Liabilities | — | 22,499,000USD | 22,933,000USD | 29,583,000USD | 33,265,000USD | 39,893,000USD | 37,309,000USD | 45,692,000USD |
| Current Deferred Revenue | — | 9,306,000USD | 8,700,000USD | 12,900,000USD | 18,942,000USD | 25,500,000USD | 22,762,000USD | 29,053,000USD |
| Net Debt | — | 13,880,000USD | -1,065,000USD | 8,890,000USD | 16,140,000USD | 15,242,000USD | 18,392,000USD | 20,956,000USD |
| Short Term Debt | — | 6,105,000USD | 6,025,000USD | 5,571,000USD | 5,508,000USD | 5,603,000USD | 5,592,000USD | 4,696,000USD |
| Short Long Term Debt Total | — | 39,186,000USD | 40,657,000USD | 41,663,000USD | 42,990,000USD | 44,437,000USD | 45,778,000USD | 46,073,000USD |
| Long Term Investments | — | 2,154,000USD | 2,154,000USD | 2,154,000USD | 2,154,000USD | 3,447,000USD | 3,447,000USD | 10,577,000USD |
| Short Term Investments | — | 114,856,000USD | 119,077,000USD | 151,341,000USD | 178,143,000USD | 196,775,000USD | 220,921,000USD | 249,470,000USD |
| Net Receivables | — | 0USD | 305,000USD | 960,000USD | 873,000USD | 1,012,000USD | 1,257,000USD | 589,000USD |
| Accounts Payable | — | 2,398,000USD | 1,489,000USD | 1,215,000USD | 2,891,000USD | 2,670,000USD | 533,000USD | 3,103,000USD |
| Property Plant Equipment Net | — | 44,921,000USD | 47,382,000USD | 49,906,000USD | 52,396,000USD | 55,195,000USD | 57,657,000USD | 59,910,000USD |
| Property Plant Equipment Gross | — | 44,921,000USD | 63,343,000USD | 49,906,000USD | 52,396,000USD | 55,195,000USD | 68,926,000USD | 59,910,000USD |
| Accumulated Other Comprehensive Income | — | -44,000USD | 260,000USD | 371,000USD | 372,000USD | 621,000USD | 709,000USD | 1,639,000USD |
| Common Stock Shares Outstanding | — | 37,581,094shares | 37,620,668shares | 37,349,449shares | 37,156,979shares | 37,019,027shares | 37,092,390shares | 36,766,309shares |
| Non Current Assets Total | — | 52,395,000USD | 55,565,000USD | 58,117,000USD | 60,603,000USD | 64,671,000USD | 66,639,000USD | 76,055,000USD |
| Non Current Liabilities Total | — | 36,669,000USD | 39,574,000USD | 39,907,000USD | 43,188,000USD | 45,315,000USD | 52,433,000USD | 56,883,000USD |
| Non Current Liabilities Other | — | 1,953,000USD | 1,953,000USD | 1,919,000USD | 2,153,000USD | 2,109,000USD | 2,010,000USD | 3,075,000USD |
| Non Currrent Assets Other | — | 5,320,000USD | 6,029,000USD | 6,057,000USD | 6,053,000USD | 6,029,000USD | 5,535,000USD | 5,568,000USD |
| Net Working Capital | — | 122,059,000USD | 142,605,000USD | 160,237,000USD | 178,416,000USD | 193,302,000USD | 220,651,000USD | 236,601,000USD |
| Unclassified Non Current Liabilities | — | 34,716,000USD | 37,621,000USD | 37,988,000USD | 41,035,000USD | 43,206,000USD | 50,423,000USD | 53,808,000USD |
| Unclassified Equity | — | 471,750,000USD | 469,198,000USD | 466,410,000USD | 463,400,000USD | 460,070,000USD | 457,142,000USD | 453,730,000USD |
| Source | 0001193125-26-342388Preliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Total Assets | 221,103,000USD | 324,599,000USD | 364,842,000USD | 414,486,000USD | 141,992,000USD |
| Other Current Assets | 4,434,000USD | 8,396,000USD | 4,640,000USD | 3,494,000USD | 272,000USD |
| Total Liab | 62,507,000USD | 89,742,000USD | 149,668,000USD | 488,914,000USD | 174,536,000USD |
| Total Stockholder Equity | 158,596,000USD | 234,857,000USD | 215,174,000USD | -74,428,000USD | -32,544,000USD |
| Other Current Liab | 6,719,000USD | 8,422,000USD | 11,472,000USD | 9,533,000USD | 7,090,000USD |
| Common Stock | 4,000USD | 4,000USD | 26,000USD | 2,535,000USD | 573,000USD |
| Capital Stock | 4,000USD | 4,000USD | 9,457,000USD | 2,535,000USD | 573,000USD |
| Retained Earnings | -310,870,000USD | -223,002,000USD | -144,944,000USD | -76,689,000USD | -33,096,000USD |
| Cash | 41,722,000USD | 27,386,000USD | 140,603,000USD | 184,441,000USD | 39,296,000USD |
| Cash And Short Term Investments | 160,799,000USD | 248,307,000USD | 271,182,000USD | 362,131,000USD | 108,154,000USD |
| Total Current Assets | 165,538,000USD | 257,960,000USD | 278,273,000USD | 366,899,000USD | 108,916,000USD |
| Total Current Liabilities | 22,933,000USD | 37,309,000USD | 68,861,000USD | 48,537,000USD | 25,172,000USD |
| Current Deferred Revenue | 8,700,000USD | 22,762,000USD | 48,905,000USD | 33,942,000USD | 16,041,000USD |
| Net Debt | -1,065,000USD | 18,392,000USD | -92,374,000USD | -165,870,000USD | 9,632,000USD |
| Short Term Debt | 6,025,000USD | 5,592,000USD | 3,427,000USD | 1,515,000USD | 687,000USD |
| Short Long Term Debt Total | 40,657,000USD | 45,778,000USD | 48,229,000USD | 18,571,000USD | 48,928,000USD |
| Long Term Investments | 2,154,000USD | 3,447,000USD | 10,676,000USD | 7,806,000USD | 6,417,000USD |
| Short Term Investments | 119,077,000USD | 220,921,000USD | 130,579,000USD | 177,690,000USD | 68,858,000USD |
| Net Receivables | 305,000USD | 1,257,000USD | 2,451,000USD | 1,274,000USD | 490,000USD |
| Accounts Payable | 1,489,000USD | 533,000USD | 1,791,000USD | 2,011,000USD | 1,354,000USD |
| Property Plant Equipment Net | 47,382,000USD | 57,657,000USD | 65,153,000USD | 33,258,000USD | 22,140,000USD |
| Property Plant Equipment Gross | 63,343,000USD | 68,926,000USD | 71,587,000USD | 35,506,000USD | 22,693,000USD |
| Accumulated Other Comprehensive Income | 260,000USD | 709,000USD | 9,334,000USD | -274,000USD | -21,000USD |
| Common Stock Shares Outstanding | 37,251,050shares | 37,418,470shares | 37,472,351shares | 37,472,351shares | 5,929,662shares |
| Non Current Assets Total | 55,565,000USD | 66,639,000USD | 86,568,999USD | 47,587,000USD | 33,076,000USD |
| Non Current Liabilities Total | 39,574,000USD | 52,433,000USD | 80,807,000USD | 440,377,000USD | 149,364,000USD |
| Non Current Liabilities Other | 1,953,000USD | 2,010,000USD | 5,079,000USD | 1,033,000USD | — |
| Non Currrent Assets Other | 6,029,000USD | 5,535,000USD | 5,491,999USD | 6,523,000USD | 4,519,000USD |
| Net Working Capital | 142,605,000USD | 220,651,000USD | 209,412,000USD | 318,362,000USD | 83,744,000USD |
| Unclassified Non Current Liabilities | 37,621,000USD | 50,423,000USD | 75,728,000USD | 439,344,000USD | 119,088,000USD |
| Unclassified Equity | 469,198,000USD | 457,142,000USD | 341,301,000USD | -2,535,000USD | — |
| Unclassified Non Current Assets | — | — | 5,248,000USD | — | — |
| Unclassified Current Liabilities | — | — | 3,266,000USD | 1,536,000USD | — |
| Long Term Debt | — | — | — | — | 30,276,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -23,059,000USD | -22,528,000USD | -20,393,000USD | -19,908,000USD | -25,039,000USD | -23,398,000USD | -18,773,000USD | -10,739,000USD |
| Depreciation | 1,275,000USD | 1,300,000USD | 1,324,000USD | 1,335,000USD | 1,358,000USD | 1,461,000USD | 1,364,000USD | 1,309,000USD |
| Stock Based Compensation | 2,552,000USD | 2,694,000USD | 3,010,000USD | 3,221,000USD | 2,928,000USD | 3,412,000USD | 3,223,000USD | 4,512,000USD |
| Other Non Cash Items | 3,527,000USD | 1,233,000USD | 442,000USD | 2,036,000USD | 189,000USD | 7,705,000USD | 102,000USD | -644,000USD |
| Change To Account Receivables | 305,000USD | 655,000USD | -87,000USD | 139,000USD | 245,000USD | -668,000USD | 1,059,000USD | 434,000USD |
| Change In Working Capital | -2,918,000USD | -6,245,000USD | -5,636,000USD | -7,935,000USD | -2,278,000USD | -15,456,000USD | -12,554,000USD | -20,747,000USD |
| Total Cash From Operating Activities | -21,175,000USD | -23,546,000USD | -21,253,000USD | -21,251,000USD | -22,842,000USD | -26,276,000USD | -26,638,000USD | -26,309,000USD |
| Capital Expenditures | -25,000USD | -85,000USD | -74,000USD | -127,000USD | -288,000USD | -334,000USD | -1,200,000USD | -665,000USD |
| Free Cash Flow | -21,200,000USD | -23,631,000USD | -21,327,000USD | -21,378,000USD | -23,130,000USD | -26,610,000USD | -27,838,000USD | -26,974,000USD |
| Investments | 4,011,000USD | 32,451,000USD | 27,363,000USD | 19,072,000USD | 24,728,000USD | 28,545,000USD | -8,934,000USD | -13,036,000USD |
| Total Cashflows From Investing Activities | 3,986,000USD | 32,366,000USD | 27,363,000USD | 19,072,000USD | 24,728,000USD | 28,545,000USD | -8,934,000USD | -13,036,000USD |
| Total Cash From Financing Activities | -27,000USD | 74,000USD | -187,000USD | -166,000USD | -77,000USD | 0USD | -492,000USD | -2,032,000USD |
| Change In Cash | -16,416,000USD | 8,894,000USD | 5,923,000USD | -2,345,000USD | 1,809,000USD | 2,269,000USD | -36,064,000USD | -41,377,000USD |
| Begin Period Cash Flow | 41,722,000USD | 38,021,000USD | 26,850,000USD | 29,195,000USD | 32,634,000USD | 30,365,000USD | 66,429,000USD | 107,806,000USD |
| End Period Cash Flow | 25,306,000USD | 46,915,000USD | 32,773,000USD | 26,850,000USD | 34,443,000USD | 32,634,000USD | 30,365,000USD | 66,429,000USD |
| Other Cashflows From Investing Activities | 360,000USD | 470,000USD | 705,000USD | 818,000USD | 1,007,000USD | — | — | — |
| Other Cashflows From Financing Activities | -27,000USD | -19,000USD | -187,000USD | -275,000USD | -77,000USD | 84,013,000USD | -8,934,000USD | -13,036,000USD |
| Unclassified Operating Cash Flow | -2,552,000USD | — | — | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | -492,000USD | -2,032,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -84,013,000USD | 8,934,000USD | 13,036,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 1,200,000USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | -2,032,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Net Income | -87,868,000USD | -78,058,000USD | -68,255,000USD | -43,593,000USD | -21,442,000USD |
| Depreciation | 5,317,000USD | 5,407,000USD | 4,207,000USD | 1,733,000USD | 387,000USD |
| Stock Based Compensation | 11,853,000USD | 16,204,000USD | 6,922,000USD | 1,962,000USD | 375,000USD |
| Other Non Cash Items | 3,900,000USD | 7,042,000USD | -7,854,000USD | 135,000USD | -1,318,000USD |
| Change To Account Receivables | 952,000USD | 1,194,000USD | -1,177,000USD | -1,274,000USD | — |
| Change In Working Capital | -22,094,000USD | -59,668,000USD | -26,429,000USD | 69,487,000USD | 46,255,000USD |
| Total Cash From Operating Activities | -88,892,000USD | -109,073,000USD | -91,409,000USD | 29,724,000USD | 24,257,000USD |
| Capital Expenditures | -574,000USD | -3,114,000USD | -9,814,000USD | -13,977,000USD | -2,903,000USD |
| Free Cash Flow | -89,466,000USD | -112,187,000USD | -101,223,000USD | 15,747,000USD | 21,354,000USD |
| Investments | 104,066,000USD | -88,157,000USD | 45,734,000USD | -122,200,000USD | -74,316,000USD |
| Total Cashflows From Investing Activities | 103,529,000USD | -88,157,000USD | 45,734,000USD | -122,200,000USD | -74,316,000USD |
| Total Cash From Financing Activities | -356,000USD | 84,013,000USD | 1,012,000USD | 239,594,000USD | 39,922,000USD |
| Issuance Of Capital Stock | 0USD | 84,013,000USD | 4,295,000USD | 239,594,000USD | 9,948,000USD |
| Change In Cash | 14,281,000USD | -113,217,000USD | -44,663,000USD | 147,118,000USD | -10,137,000USD |
| Begin Period Cash Flow | 32,634,000USD | 145,851,000USD | 190,514,000USD | 43,396,000USD | 53,533,000USD |
| End Period Cash Flow | 46,915,000USD | 32,634,000USD | 145,851,000USD | 190,514,000USD | 43,396,000USD |
| Other Cashflows From Investing Activities | 3,000,000USD | — | — | -108,223,000USD | -71,413,000USD |
| Other Cashflows From Financing Activities | -558,000USD | — | 1,012,000USD | 239,594,000USD | 9,948,000USD |
| Unclassified Investing Cash Flow | -2,963,000USD | 3,114,000USD | 9,814,000USD | 122,200,000USD | 74,316,000USD |
| Unclassified Financing Cash Flow | — | — | -4,295,000USD | -239,594,000USD | -9,948,000USD |
| Net Borrowings | — | — | — | 0USD | 29,974,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.